GA4 (398745346)

Tasly Shaoma Zhispasm Granules help children grow up healthily

Tasly Shaoma Zhispasm Granules help children grow up healthily


Recently, the “Third China Children’s Health Conference on the Integration of Chinese and Western Medicine” was held in Guangzhou. Tasly was invited to participate in the conference and share and communicate as an industry representative.

Tasly participated in the conference and shared and exchanged industry experience

The China Children’s Health Conference on the Integration of Chinese and Western Medicine is hosted by the China Association of Traditional Chinese Medicine and the China Medical Education Association. It is a national academic event. With the theme of “Combining Traditional Chinese and Western Medicine to Create a New Future of Children’s Health”, this conference gathers the strength of Chinese and Western medicine pediatric experts to overcome the hotspots, highlights and difficulties of the integration of Chinese and Western medicine, and promote the integration of the two systems of Chinese and Western medicine in pediatrics , to promote the complementary advantages of the two disciplines of Chinese and Western medicine.

In the “Exhibition of Evidence-Based Medicine Research Project Achievements”, as a neuropsychiatric drug, Tasly’s “Shaoma Zhishang Granule” has attracted much attention. Professor Zheng Yi, chief expert of child psychiatry at Beijing Anding Hospital Affiliated to Capital Medical University, said: “Shaoma Zhishang Granules is the first innovative Chinese medicine for children recommended by European and American guidelines with strong evidence. The results of its phase III clinical study were published in JOURNAL of CHILD PSYCHOLOGY AND PSYCHIATRY.”


Professor Zheng Yi, chief expert of child psychiatry at Beijing Anding Hospital Affiliated to Capital Medical University, delivered a speech

Professor Zheng Yi also pointed out that “Shaoma Zhishang Granules are equivalent to the first-line drugs in the guidelines for tic disorders, and the incidence of neuropsychiatric adverse reactions is significantly lower than that of the first-line drugs. It is a Chinese patent medicine for moderate to severe patients.” It was listed in the “2020 National Medical Insurance Negotiation Drug Catalog” and the “Mental Disorder Diagnosis and Treatment Standards (2020 Edition)” issued by the National Health and Medical Commission. The European Society for the Study of Tourett Syndrome (ESSTS) “European Clinical Guidelines for Tourett Syndrome and Other Tic Disorders—Version 2.0” points out in the drug treatment section that: the number of effective new drugs for the treatment of Tourette syndrome is limited, and perhaps the most promising is the traditional Chinese medicine product peony Antispasmodic granules.

“Shaoma Zhishang Granule” is a modern traditional Chinese medicine approved by Tasly for marketing based on the empirical prescription developed by Academician Wang Yongyan of the Chinese Academy of Engineering. It makes up for the unmet clinical needs that current similar Chinese patent medicines are only suitable for mild to moderate patients. The published SCI articles have been cited many times and gained international recognition.



Source link